|
|
Lipid peroxidation and ferroptosis |
| | | | | |
|
Ferroptosis is an iron- and ROS-dependent form of regulated cell death. It is driven by the activity loss of lipid repair enzyme GPX4 and subsequent lipid peroxidation. Misregulated ferroptosis has been implicated in multiple physiological and pathological processes such as cancer cell death, tissue injury, and T-cell immunity. More understanding the molecular mechanism of ferroptosis will provide insights into the new therapeutic strategies for ferroptosis-associated diseases. arigo offers a series of quality ELISA kits and antibodies against lipid peroxidation or ferroptosis markers to facilitate related research | | |
| | | |
|
ELISA kits for lipid peroxidation markers | | |
| | | |
|
|
|
MDA (Malondialdehyde) ELISA Kit |
|
(ARG81237) |
|
| |
|
|
MG (Methylglyoxal) ELISA Kit |
|
(ARG81131) |
|
| |
|
|
3-NT (3-Nitrotyrosine) ELISA Kit |
|
(ARG81132) |
|
| | |
| | | |
|
|
Lipid peroxidation marker antibodies | | |
| | | |
|
|
|
3-NT (3-Nitrotyrosine) antibody [39B6] (ARG22269) |
|
Application: ELISA, FACS, ICC/IF, IHC, IP, WB |
|
| |
|
|
4-HNE (4-Hydroxynonenal) antibody [12F7] (ARG23717) |
|
Application: ELISA, ICC/IF, WB |
|
| | |
| | | |
|
|
|
7-KC (7-Ketocholesterol) antibody [3F7] (ARG22619) |
|
Application: ICC/IF, WB |
|
| |
|
|
ACR (Acrolein) antibody [10A10] (ARG22620) |
|
Application: FACS, ICC/IF, WB |
|
| | |
| | | |
|
|
|
CRA (Crotonaldehyde) antibody [2A8.1] (ARG23718) |
|
Application: Dot, WB |
|
| |
|
|
HEL (Hexanoyl-Lysine) antibody [5D9] (ARG22630) |
|
Application: ICC/IF, WB |
|
| | |
| | | |
|
|
|
MDA (Malondialdehyde) antibody [11E3] (ARG22631) |
|
Application: ICC/IF, WB |
|
| |
|
|
MG (Methylglyoxal) antibody [9E7] (ARG22633) |
|
Application: FACS, ICC/IF, WB |
|
| | |
| | | |
|
|
Ferroptosis marker antibodies | | |
| | | |
|
|
|
SLC7A11 / xCT antibody (ARG57998) |
|
Reactivity: Hu, Ms Application: WB |
|
| |
|
|
GPX4 antibody (ARG59682) |
|
Reactivity: Hu, Ms, Rat Application: IHC-P, WB |
|
| | |
| | | |
|
© 2019 arigo Biolaboratories |
| | |